Doximity (NYSE:DOCS) surges 70% before market open as investors factor in AI Search revenue shift
Doximity (NYSE:DOCS) shares jumped about 70% in premarket trading after the company raised its fiscal-year revenue outlook midpoint by $6 million to $676 million, while lowering adjusted EBITDA midpoint by $10 million to $319 million. The firm reported zero AI Search revenue in the quarter, with most AI Search contracted revenue expected in fiscal Q3.
How this was made
The 30-second read
Why it matters
Traders are repricing DOCS on raised revenue guidance and improving AI Search query activity, but the profit outlook and margin trajectory are explicitly weaker, making Q3 recognition timing the key swing factor.
Market read
A same-day guidance update is driving a major premarket repricing, with the market’s core debate centered on whether AI Search contracted revenue will convert into recognized revenue in fiscal Q3.
What to watch
Premarket liquidity risk and the stated Q2 revenue outlook being 0.8% below the Street midpoint could cause a sharp unwind if early trading fails to confirm the AI-driven re-rating.
Background
The article frames Doximity’s move as a valuation shift toward AI Search growth, while noting AI Search generated zero revenue in the just-reported quarter.
Ticker impact
Doximity surged about 70% premarket after raising full-year revenue guidance midpoint by $6M while cutting adjusted EBITDA midpoint by $10M.
Elevated volatility likely persists into the cash open and through Q3, when AI Search contracted revenue is expected to be recognized.
The article cites a large premarket repricing tied to specific guidance changes and highlights that AI Search revenue was zero in the quarter, shifting the key earnings test to Q3.
Market effects
Reinforces the market’s willingness to re-rate healthcare IT names on AI monetization narratives, even when profitability guidance is pressured.
Primarily US small-to-mid cap growth sentiment, with potential spillover to other digital health and clinical workflow platforms.
Limited direct global impact; the story is mainly about US-listed healthcare software valuation and AI product adoption timing.
Counterpoint
The guidance mix may be less about durable operating leverage and more about front-loaded AI investment, with AI Search revenue still not recognized in the reported quarter.
Key entities
- public_companyDoximity
DOCS, healthcare communications platform; raised FY revenue midpoint by $6M and lowered adjusted EBITDA midpoint by $10M, with AI Search revenue still reported as zero in the quarter.
- executiveJeff Tangney
CEO quoted saying Doximity Ask was the top-performing US-based model and reporting prescriber workflow and AI Search query growth.
